These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Drug equilibration across the blood-brain barrier--pharmacokinetic considerations based on the microdialysis method. Hammarlund-Udenaes M; Paalzow LK; de Lange EC Pharm Res; 1997 Feb; 14(2):128-34. PubMed ID: 9090698 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats. Delon A; Huguet F; Courtois P; Vierfond JM; Bouquet S; Couet W J Pharmacol Exp Ther; 1997 Feb; 280(2):983-7. PubMed ID: 9023315 [TBL] [Abstract][Full Text] [Related]
26. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Welty DF; Schielke GP; Vartanian MG; Taylor CP Epilepsy Res; 1993 Dec; 16(3):175-81. PubMed ID: 8119268 [TBL] [Abstract][Full Text] [Related]
27. Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Jusko WJ; Ko HC Clin Pharmacol Ther; 1994 Oct; 56(4):406-19. PubMed ID: 7955802 [TBL] [Abstract][Full Text] [Related]
28. Effect of norfloxacin on theophylline disposition: a comparison with other fluoroquinolones. Davis JD; Aarons L; Houston JB Pharm Res; 1995 Feb; 12(2):257-62. PubMed ID: 7784342 [TBL] [Abstract][Full Text] [Related]
29. Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model. Fuseau E; Sheiner LB Clin Pharmacol Ther; 1984 Jun; 35(6):733-41. PubMed ID: 6329584 [TBL] [Abstract][Full Text] [Related]
30. Central nervous system toxicity of quinolones: human and animal findings. Christ W J Antimicrob Chemother; 1990 Oct; 26 Suppl B():219-25. PubMed ID: 2124211 [TBL] [Abstract][Full Text] [Related]
31. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Sheiner LB; Stanski DR; Vozeh S; Miller RD; Ham J Clin Pharmacol Ther; 1979 Mar; 25(3):358-71. PubMed ID: 761446 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology. Barker CI; Germovsek E; Hoare RL; Lestner JM; Lewis J; Standing JF Adv Drug Deliv Rev; 2014 Jun; 73(100):127-39. PubMed ID: 24440429 [TBL] [Abstract][Full Text] [Related]
33. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Martinez MN; Papich MG; Drusano GL Antimicrob Agents Chemother; 2012 Jun; 56(6):2795-805. PubMed ID: 22371890 [TBL] [Abstract][Full Text] [Related]
34. Electroencephalogram-based pharmacodynamic measures: a review. Bewernitz M; Derendorf H Int J Clin Pharmacol Ther; 2012 Mar; 50(3):162-84. PubMed ID: 22373830 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin in rats. Chenel M; Barbot A; Dupuis A; Mimoz O; Paquereau J; Bouquet S; Couet W Antimicrob Agents Chemother; 2003 Jun; 47(6):1952-7. PubMed ID: 12760873 [TBL] [Abstract][Full Text] [Related]